Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors

详细信息    查看全文

• 作者：Vivek Verma ; Valerie K. Shostrom ; Sameera S. Kumar ; Weining Zhen ; Christopher L. Hallemeier ; Steve E. Braunstein ; John Holland ; Matthew M. Harkenrider ; Adrian S. Iskhanian ; Hanmanth J. Neboori ; Salma K. Jabbour ; Albert Attia ; Percy Lee ; Fiori Alite ; Joshua M. Walker ; John M. Stahl ; Kyle Wang ; Brian S. Bingham ; Christina Hadzitheodorou ; Roy H. Decker ; Ronald C. McGarry and Charles B. Simone II
• 刊名：Cancer
• 出版年：2017
• 出版时间：February 15, 2017
• 年：2017
• 卷：123
• 期：4
• 页码：688-696
• 全文大小：186K
• ISSN：1097-0142

文摘

Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonoperative, early-stage non–small cell lung cancer (NSCLC) measuring < 5 cm, but its use among patients with tumors measuring ≥5 cm is considerably less defined, with the existing literature limited to small, single-institution reports. The current multi-institutional study reported outcomes evaluating the largest such population reported to date.